• Rehm Replaces Haussler As GA4GH Vice Chair, Other Changes

    Bio-IT World Brief  GA4GH announced several changes in leadership. GA4GH Vice Chair David Haussler, Scientific Director of the University of California Santa Cruz Genomics Institute, will be succeeded by Heidi Rehm,an institute member at the Broad Institute of MIT and Harvard and chief genomics officer at Massachusetts General Hospital. 

    Dec 10, 2018
  • 10x Genomics Acquires Spatial Genomics Company

    Bio-IT World Brief   10x Genomics has acquired Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one another, offering up invaluable insight into understanding disease.

    Dec 10, 2018
  • A Mature Capital Structure Positions Bio-IT Startups For Success

    Bio-IT World Contributed Commentary | By establishing a mature capital structure reflecting a healthy balance of both equity and debt, early-stage bio-IT companies can project long-term strength and vision that helps to favorably position them with their stakeholders.

    Dec 6, 2018
  • GSK Bags Tesaro For $5B As It Leaps Back Into Commercial Oncology, Beefs Up Cancer Drug Pipeline

    Endpoints News | GlaxoSmithKline has struck a deal to buy Tesaro in a $5.1 billion deal that will vault the pharma giant into the commercial oncology market as it stakes out a big new role for itself in the booming cancer field.

    Dec 5, 2018
  • OmniTier Debuts CompStor Novos Platform For De Novo Assembly-Based Variant Calling

    Bio-IT World News Brief | OmniTier has debuted the CompStor Novos platform for de novo assembly-based variant calling in whole genome sequencing applications.

    Dec 5, 2018